Largest Diagnostics & Research Companies by Market Cap
Largest Diagnostics & Research companies by market cap. The Diagnostics & Research sector has 167 publicly listed stocks with a combined market cap of $1.09 Trillion. Imagion Biosystems Ltd leads the sector with a market cap of $1.74 Million. This ranking covers all Diagnostics & Research stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Diagnostics & Research Stocks by Market Capitalization (October 2026)
Top Diagnostics & Research stocks by market capitalization as of October 2026, covering 167 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 151 |
Imagion Biosystems Ltd
AU:IBX |
$1.74 Million | AU$2.45 Million | Australia | AU$0.01 | +0.00% | +0.00% | 40.89 Million |
| 152 |
Inotiv Inc
NASDAQ:NOTV |
$1.26 Million | $1.26 Million | USA | $0.04 | -28.00% | -58.43% | 1.22 Billion |
| 153 |
LUNGLIFE AI INC. DL-0001
F:9H4 |
$1.06 Million | €904.73K | Germany | €0.03 | +0.00% | +0.00% | 1.00K |
| 154 |
Wellfully Ltd
AU:WFL |
$1.05 Million | AU$1.48 Million | Australia | AU$0.00 | +0.00% | +0.00% | 0.00 |
| 155 |
ALPHAHELIX MOL.DIAGN. SK1
F:4MB |
$719.69K | €615.59K | Germany | €0.01 | +50.00% | -10.00% | 0.00 |
| 156 |
Prostatype Genomics AB
ST:PROGEN |
$684.74K | Skr6.36 Million | Sweden | Skr0.11 | +0.47% | +11.98% | 170.11 Million |
| 157 |
CHINA HEALTH GRP HD-10
F:VNL1 |
$581.84K | €497.68K | Germany | €0.00 | +0.00% | -50.00% | 0.00 |
| 158 |
Inotiv, Inc.
NASDAQ:NOTVQ |
$390.42K | $390.42K | USA | $0.01 | +0.00% | -34.71% | 6.43 Million |
| 159 |
Abingdon Health Plc
LSE:ABDX |
$274.94K | GBX2.26 Billion | UK | GBX9.00 | +0.00% | +0.00% | 2.86 Million |
| 160 |
ProPhase Labs Inc
NASDAQ:PRPH |
$238.57K | $238.57K | USA | $0.02 | -9.47% | -27.14% | 6.73 Million |
| 161 |
genedrive plc
LSE:GDR |
$122.14K | GBX1.00 Billion | UK | GBX0.98 | -2.50% | -9.30% | 60.80 Million |
| 162 |
ANGLE plc
LSE:AGL |
$94.18K | GBX774.07 Million | UK | GBX2.40 | +0.00% | +0.00% | 1.50 Million |
| 163 |
Proteome Sciences PLC
LSE:PRM |
$62.09K | GBX510.30 Million | UK | GBX1.46 | -0.34% | +8.18% | 2.32 Million |
| 164 |
Oxford Biodynamics PLC
LSE:OBD |
$55.08K | GBX452.69 Million | UK | GBX0.11 | -4.09% | -4.09% | 800.70 Million |
| 165 |
Verici Dx Plc
LSE:VRCI |
$42.35K | GBX348.08 Million | UK | GBX0.23 | +6.98% | +2.22% | 486.48 Million |
| 166 |
LungLife AI Inc
LSE:LLAI |
$15.48K | GBX127.23 Million | UK | GBX4.15 | +0.00% | +0.00% | 1.43 Million |
| 167 |
Biocept Inc.
NASDAQ:BIOCQ |
$262.00 | $262.00 | USA | $0.00 | +0.00% | +0.00% | 19.35K |
How Diagnostics & Research Companies Are Ranked by Market Cap
Diagnostics & Research companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Diagnostics & Research industry. Compare marketcap, analyze stock performance, and discover leading diagnostics & research corporations. View all industries